Full List Of Stories
Volkswagen undergoes first legal test case over emissions in Germany
Consumer rights organisation myRight has filed the first legal test case against Volkswagen in Germany, putting pressure on the car giant to compensate customers in Europe over the emissions scandal, Reuters reports.
OECD predicts worldwide property bubble burst
The Organisation for Economic Cooperation and Development has issued a warning that global property prices could overheat and eventually drop.
Intense competition curbs supermarket price hikes
Supermarkets in the UK raised their prices in December from the previous month, however the hike was lower than the previous year due to competition curbing the impact of a Brexit-caused cost inflation, according to mySupermarket. com .
UK's EU representative quits before Brexit talks
Britain’s EU ambassador Ivan Rogers has prematurely quit months before the formal Brexit talks are to commence in March.
WPP adds Brazilian digital marketing muscle
Advertising giant WPP has acquired a majority stake in Brazilian digital marketing specialist Pmweb Comunicação.
Europe midday: Chinese manufacturing data boosts stocks
European stocks stayed in the green as basic resources rallied on upbeat Chinese manufacturing data, while stronger oil prices also lent a hand.
McCarthy & Stone appoints group financial controller as CFO
McCarthy & Stone, the UK’s leading retirement housebuilder, has announced that Rowan Baker will be appointed as the group’s chief financial officer from 6 January 2017.
Morrisons slashes prices for 800 grocery items
Morrisons has started off the new year by initiating the supermarket price war, cutting prices on 800 of its items.
Aveva appoints new CEO and president
Aveva Group, a provider of engineering data and design IT systems, has confirmed the appointment of former deputy chief executive James Kidd as chief executive from 1 January 2017.
Tiziana Life Sciences obtains exclusive license for new inflammation treatment
Tiziana Life Sciences has announced the acquisition of an exclusive world-wide license for NI-1201, a fully human anti-interleukin-6 receptor (IL-6R) monoclonal antibody (mAb), from Novimmune SA.